- Home
- FOX vs BNTX Comparison
FOX vs BNTX Comparison
Compare FOX & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FOX | BNTX |
|---|---|---|
| Founded | 2018 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.2B | 24.8B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | FOX | BNTX |
|---|---|---|
| Price | $64.59 | $116.77 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $140.31 |
| AVG Volume (30 Days) | ★ 1.3M | 1.0M |
| Earning Date | 02-04-2026 | 03-10-2026 |
| Dividend Yield | ★ 0.86% | N/A |
| EPS Growth | ★ 9.15 | N/A |
| EPS | ★ 4.44 | N/A |
| Revenue | ★ $16,474,000,000.00 | $3,698,814,972.00 |
| Revenue This Year | $0.56 | $2.03 |
| Revenue Next Year | $4.22 | N/A |
| P/E Ratio | $14.47 | ★ N/A |
| Revenue Growth | ★ 14.90 | 3.70 |
| 52 Week Low | $43.18 | $81.20 |
| 52 Week High | $68.18 | $126.77 |
Technical Indicators
Market Signals| Indicator | FOX | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 47.90 | 66.72 |
| Support Level | $64.09 | $114.61 |
| Resistance Level | $65.99 | $120.16 |
| Average True Range (ATR) | 1.06 | 3.66 |
| MACD | -0.41 | 1.05 |
| Stochastic Oscillator | 12.56 | 71.23 |
Price Performance
Historical ComparisonAbout FOX Fox Corporation Class B
Fox operates in two segments: cable networks and television. Cable networks primarily includes Fox News, Fox Business, and several pay TV sports stations. Television primarily includes the Fox broadcast network, 29 owned and operated local television stations, of which 18 are affiliated with the Fox network, and streaming platform Tubi, which is not subscription-based and is completely ad-supported. Fox effectively sold most of its entertainment assets to Disney in 2019, so it no longer creates entertainment content and relies heavily on live news and sports, with nearly all tied to the pay TV bundle. The Murdoch family controls Fox.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.